HHL & HHLE | Healthcare: A Defensive Play in Late 2025
Healthcare seeks for catalysts as valuations remain low, which could make the Harvest Healthcare Leaders Income ETF (TSX: HHL) intriguing.
The Skinny | GLP-1s History & Outlook to 2030
The GLP-1 drug class has transformed the weight loss industry, resulting in what could grow into a $100 billion+ market by 2030.
Taking a Breather | Healthcare in Summer 2025
Healthcare looks like a value opportunity. Canada’s largest healthcare ETF – HHL – offers access to top healthcare stocks and monthly income.
Healthcare ETFs in the age of noise: Why advisors are still turning to sector stability
As markets churn and rate cycles shift, Harvest’s Chris Heakes explains why lower-risk equities might just punch above their weight
Unlock Healthcare Value and Monthly Income | HHL & HHLE
Access the value in the US Healthcare sector and monthly income with the Harvest Healthcare Leaders Income ETF.
Using Weight Loss to Add Weight to Your Portfolio
The Harvest Eli Lilly High Income Shares ETF (LLHE-T) provides access to the upside of Eli Lilly’s weight loss drugs and high monthly income.
Paul MacDonald’s Market Outlook: Large cap healthcare stocks
Paul MacDonald, CIO and portfolio manager at Harvest Portfolios Group, shares his outlook on the market.
Fund Spotlight: Harvest Healthcare Leaders (HHL)
The Harvest Healthcare Leaders Income ETF (HHL:TSX) provides access to large-cap global healthcare for Canadians.
How is AI Impacting Healthcare?
AI development could improve efficiencies for global healthcare leaders that are held in the Harvest Healthcare Leaders Income ETF (HHL:TSX).
Healthcare: Catalysts and Innovations | Harvest Market Minutes
Harvest ETFs CIO Paul MacDonald highlights the catalysts and innovations that are positioned to transform the healthcare sector.
Global Healthcare: A Unique Long-Term Opportunity
Healthcare benefits from long-term drivers as the Harvest Healthcare Leaders Income ETF (HHL:TSX) approaches 10 years running.
The Impact of FDA Approvals on Healthcare Stocks
Discover how FDA approvals and regulations can affect healthcare stocks and influence the investment landscape.